Selling a Welland Engineering Firm While a Partner Balks

The situation

The number on the table was roughly seven million dollars. That was the price a dentist named Doris had agreed to pay for a controlling interest in the Welland engineering firm that Miriam had spent two decades building. Miriam was ready to retire. Her share of the sale would fund the next chapter of her life, and after months of negotiation the deal terms were set: purchase price, closing date, and a list of conditions both sides needed satisfied before money changed hands.

Doris was not an engineer herself. She had built a successful dental practice over the years and, like many owners of a stable professional practice, was looking for a place to put capital that would keep generating income after she eventually stepped back from clinical work. The engineering firm's client contracts, mostly long-running municipal and institutional work, looked to her like exactly that kind of asset: predictable, recurring, and not tied to her own labour.

The complication was Cynthia. Cynthia was Miriam's business partner, holding a substantial minority stake in the firm, and Cynthia did not want to sell. She had built her career there too, and she was not persuaded that a buyout under these terms was in her interest. Under the firm's partnership agreement, Miriam could not force a sale of the whole business without either Cynthia's cooperation or a mechanism that let the deal proceed around her.

Layered on top of that was a second problem neither side controlled. The firm held a permit to practice issued by the professional engineering regulator, and that permit could not simply be assigned to a new controlling owner. The regulator had to review and approve the change, and its processing queue moved on its own schedule, not the parties' schedule. Nobody could promise a date, and every prior conversation Miriam had with the regulator's office confirmed only that the review would take as long as it took.

Doris was a serious buyer, but she was not going to leave her money committed indefinitely while a regulator worked through its queue and a reluctant partner dug in. If the deal was going to survive both problems at once, the purchase agreement had to be built to absorb delay without collapsing, and to give Miriam a lawful path forward even if Cynthia never came around. Miriam, for her part, wanted to leave the firm on good terms with the partner she had worked beside for years, which meant the solution also had to be one Cynthia could live with, even reluctantly.

The problem

A conditions precedent clause lists the things that must happen before a sale becomes binding and money moves. In most business sales, these are routine: financing confirmed, key contracts assigned, no material change in the business. Here, two of the conditions were unusually hard to control. One was regulatory approval of the ownership change, which depended entirely on the pace of an external body. The other was Cynthia's cooperation, which depended on a person who had already said she was not interested in selling.

Left as an open-ended condition, either one could sit unresolved for months. Doris's lawyers, reasonably, did not want their client's capital locked into a deal with no defined end point. If the regulatory approval or the partner issue was still outstanding a year from now, Doris needed to be able to walk away and put her money elsewhere. But an outside date that was too tight risked killing a deal that both principals wanted, over a delay that was nobody's fault.

The partnership agreement gave Miriam a right to sell her own interest even without Cynthia's consent, but it was silent on what happened if the buyer wanted control of the whole firm rather than just Miriam's share. Doris had made clear she was buying a controlling position, not a minority one alongside an unhappy partner. That meant the deal needed a structure where Cynthia's interest could be addressed separately from the timeline that governed everything else, without giving her an effective veto over whether the sale happened at all.

The risk, in short, was two independent clocks running on the same deal: a regulator's clock nobody could speed up, and a reluctant partner's clock that could run out the parties' patience long before the regulator finished. Either clock, mishandled, could sink a transaction both sides otherwise wanted.

There was also a financing wrinkle that made the timing pressure worse. Doris's bank had approved lending tied to this specific acquisition, but the approval itself had a shelf life; if the deal dragged on too long past the bank's underwriting date, she would need to reapply and requalify under whatever lending conditions existed at that later point, which could mean a different rate or a reduced amount. That gave Doris her own reason to want a firm outside date, separate from any patience she had for Cynthia's reluctance or the regulator's pace.

What we did

1. Separated the regulatory condition from every other condition in the agreement. We drafted the permit-to-practice approval as its own standalone term with its own extension mechanism, rather than bundling it into a general due diligence or financing clause, so a delay in one did not trigger a false default on the others and neither party could use one issue as leverage against an unrelated one.
2. Built a waiver deadline into the regulatory condition rather than an open-ended wait. The clause set an outside date for approval, with a defined number of short extensions either party could invoke once, so Doris was never asked to leave her financing committed with no end in sight, and Miriam was never at risk of the deal dying the moment the regulator went quiet for a few weeks.
3. Negotiated a separate buyout mechanism for Cynthia's minority interest. Rather than making the whole sale conditional on Cynthia's agreement, we structured a parallel process where her interest could be purchased on formula-based terms already set out in the partnership agreement, giving Miriam a lawful route to deliver control to Doris without Cynthia's active cooperation or sign-off. This kept the two problems from feeding each other, since Cynthia no longer had any way to use her reluctance about the sale to extract better terms for herself than the formula already provided.
4. Gave Cynthia formal notice and a real opportunity to respond. We made sure the buyout process followed the partnership agreement's notice requirements precisely, because a shortcut here would have exposed the whole transaction to a later legal challenge from Cynthia over improper process rather than the substance of the price she was offered for her interest. Every notice went out on the schedule the agreement specified, with proof of delivery kept on file, so there was no procedural opening left for a dispute months after the sale had already closed.
5. Coordinated directly with the regulator's transfer office. We prepared the ownership change application early, with every document the regulator was known to ask for included upfront, to avoid the common cause of delay: an incomplete application sent back for resubmission and pushed to the back of the queue behind newly filed requests. We also called the transfer office directly before submitting, to confirm the current checklist rather than relying on a form that had changed since the last transaction we had run through that office.
6. Drafted a holdback tied to any post-closing regulatory conditions. In case the regulator approved the transfer subject to minor conditions, such as a requirement that a specific senior engineer remain the firm's designated responsible party, we built a modest purchase-price holdback so Doris was protected without needing to renegotiate the whole deal at the last minute. A holdback drafted in advance meant a routine regulatory condition could be satisfied and released on its own timeline, instead of becoming a fresh negotiation between two parties who had already agreed on everything else.
7. Aligned the financing condition's deadline with the regulatory condition's deadline. We worked with Doris's lender to extend the underwriting shelf life to match the outside date on the regulatory approval, so a slow regulator would not accidentally force Doris to requalify for financing on worse terms through no fault of her own. Without this step, the two deadlines that mattered most to the deal would have been running on different clocks, and either one could have forced a costly restart of the other at the worst possible moment.
8. Kept both principals updated on a fixed schedule rather than only when something changed. Weekly status updates, even when the honest update was 'still waiting on the regulator', kept both sides from assuming the silence meant the deal was dead and reaching for their own lawyers to pull out prematurely. This mattered most for Cynthia, who had no reason to trust that a process she had not wanted in the first place was actually moving forward, and a predictable update rhythm gave her less reason to escalate out of frustration alone.

The outcome

The regulator's approval came through eleven days before the outside date the agreement had set, close enough that the waiver mechanism nearly had to be used but never was. The sale closed at the originally agreed price, with Doris taking the controlling interest she had bargained for and Miriam receiving the full value of her stake in the firm she had spent two decades building. The financing extension negotiated with Doris's lender turned out to matter as much as the regulatory waiver clause itself, since without it the delay would have pushed her past the bank's original underwriting window regardless of how the regulatory piece resolved.

Cynthia's buyout proceeded on the formula terms set out in the partnership agreement. She was not pleased with the outcome, but the process followed the agreement's notice and valuation steps exactly, and no challenge to the buyout was ever raised. She received fair value for her minority interest and exited the firm on terms that had been fixed years before this sale was ever contemplated, which removed most of the room for dispute. Miriam later said the hardest part of the whole process was not the paperwork but sitting across from a partner of many years knowing the outcome had already been decided by an agreement they had both signed long before either of them imagined this day.

What made the difference was treating the regulatory delay and the reluctant partner as two separate problems requiring two separate mechanisms, rather than one general condition that either issue could derail. A single all-purpose 'subject to regulatory approval and partner consent' clause would have left Doris exposed to an open-ended wait and given Cynthia effective leverage to block a sale she had no legal right to prevent. Structuring each risk on its own track, with its own deadline and its own fallback, let the deal absorb the delay it could not avoid, and remove the objection it did not have to accept.

What you can learn from this